From: Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
Tumors with later progression | Tumors with no progression | Totals | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Stage/Grade | TaG2* | TaG2 | TaG3/CIS | T1G2 | T1G3 | TaG2 | TaG3/CIS | T1G2 | T1G3 | ||
Primary tumors | SNP microarray | 1 | 1 | 10 | 10 | 22 | |||||
QPCR only | 3 | 1 | 1 | 10 | 6 | 16 | 37 | ||||
Total primary tumors | 4 | 1 | 2 | 20 | 6 | 26 | 59 | ||||
Secondary tumors | SNP microarray | 1 | 2 | 6 | 6 | 2 | 4 | 1 | 4 | 26 | |
QPCR only | 2 | 4 | 9 | 10 | 4 | 5 | 2 | 4 | 40 | ||
Total secondary tumors | 3 | 6 | 15 | 0 | 16 | 6 | 9 | 3 | 8 | 66 | |
Stage distribution (totals) | 7 | 6 | 16 | 2 | 36 | 6 | 9 | 6 | 26 | 125 | |
Mean age (range) | 72.4 (54–85) | 68.4 (46–83) | |||||||||
Gender | Male | 54 | 44 | 98 | |||||||
Female | 13 | 14 | 27 | ||||||||
Totals | 67 | 58 | 125 |